Pharma Stocks surge After US Senate Passes Biosecure Act; Nifty Pharma Gains
Pharmaceutical stocks surged on December 19 after the US Senate passed the Biosecure Act as part of the fiscal 2026 National Defense Authorization Act (NDAA), a move seen as structurally positive for Indian drug makers. The rally pushed the Nifty Pharma index up 0.65% to 22,704, after hitting an intraday high of over 1.35%. Investor […]
Pharma Stocks surge After US Senate Passes Biosecure Act; Nifty Pharma Gains Read More »